Many Cancer Drugs Still Unproven 5 Years After Accelerated Approval

MONDAY, April 8, 2024 -- New research questions the effectiveness of the U.S. Food and Drug Administration ' s accelerated drug approval program after finding that many cancer drugs remain unproven five years later.The study, published Sunday in the...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news